Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stentimplantation (CILON-T)' study: A multicenter andomized trial evaluating the efficacy of Cilostazol on ischemic vascular complicationsafter drug-eluting stent implantation for coronary heart disease

MLA

Seung-Pyo Lee, et al. “Study Design and Rationale of ‘Influence of Cilostazol-Based Triple Anti-Platelet Therapy on Ischemic Complication after Drug-Eluting Stentimplantation (CILON-T)’ Study: A Multicenter Andomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complicationsafter Drug-Eluting Stent Implantation for Coronary Heart Disease.” Trials, vol. 11, Jan. 2010, pp. 87–94. EBSCOhost, https://doi.org/10.1186/1745-6215-11-87.

APA

Seung-Pyo Lee, Jung-Won Suh, Kyung Woo Park, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, In-Ho Chae, Dong-Ju Choi, Seung-Woon Rha, Jang-Whan Bae, Myeong-Chan Cho, Taek-Geun Kwon, Jang-Ho Bae, & Hyo-Soo Kim. (2010). Study design and rationale of “Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stentimplantation (CILON-T)” study: A multicenter andomized trial evaluating the efficacy of Cilostazol on ischemic vascular complicationsafter drug-eluting stent implantation for coronary heart disease. Trials, 11, 87–94. https://doi.org/10.1186/1745-6215-11-87

Chicago

Seung-Pyo Lee, Jung-Won Suh, Kyung Woo Park, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, In-Ho Chae, et al. 2010. “Study Design and Rationale of ‘Influence of Cilostazol-Based Triple Anti-Platelet Therapy on Ischemic Complication after Drug-Eluting Stentimplantation (CILON-T)’ Study: A Multicenter Andomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complicationsafter Drug-Eluting Stent Implantation for Coronary Heart Disease.” Trials 11 (January): 87–94. doi:10.1186/1745-6215-11-87.